Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 4439 Nasopharyngeal carcinoma is a malignancy which is highly associated with the Epstein-Barr virus (EBV). It has been proposed that NPC initiation depends on EBV expression. As the key oncogenic protein, EBV encoded latent memebrane protein 1 (LMP1) plays an important role in carcinogenesis of NPC. However, studies of LMP1 have been mainly focused on the B lymphoma cells and other tumor cells. So using the immortalized NP cells established from primary nonmalignant nasopharyngeal epithelial cells may represent a novel cell model system for studying the mechanism involved in the tumorigenesis of NPC. p53 is an important tumor-suppressor gene, which is believed to be important in multistage human carcinogenesis. Phoshporylation of p53 protein is likely to play the key role in regulating its activity. Mechanisms other than mutation can cause p53 inactivation in human malignancies, for instance the binding of viral proteins. In NPC, p53 protein accumulates but mutation of p53 gene is not common. It is reported that the expression of p53 correlated with malignant stage. To date, the function of p53 remains uncertain in NPC. In this study, we choose immortalized nasopharyngeal carcinoma cells NP69, and respectively stable transfected control vector (NP69-pLNSX), LMP1 plasmid (NP69-LMP1) as an experimental model. LMP1 could induce many phenotypic changes in NP69 cells, including morphologic transformation, anchorage-independent growth, resistance to serum free-induced cell death, and enhanced cell migration and invasion. We present data to show that p53 is not mutated in the carcinogenesis of NPC. LMP1 can upregulate the expression of p53 protein and promote the accumulation of p53 protein in the nucleus. Ionizing radiation (5Gy) and reporter gene assay indicated that p53 is functional in LMP1-expressing cells. More interestingly, p53 can be activated and phosphorylated clearly at serine 15, serine 20, serine 392 and threonine 81 induced by LMP1. Transient transfection assay further confirm that LMP1 can regulate the phosphorylation of p53. We also provide evidence that LMP1-induced phosphorylation of p53 at serine 15 is directly by ERKs kinase; at serine 20 and threonine 81 by JNK kinase, at serine 392 by p38 kinase. We find that LMP1 can promote ERK, JNK and p38 to form the complex with p53 following the initiation of LMP1 expression. These results strongly suggest that ERKs, JNK and p38 kinase have a direct role in LMP1-induced phsophorylation of p53 at multiple site in the carcinogenesis of nasopharyngeal carcinoma.

Latent Membrane Protein 1 of Epstein-Barr Virus Regulates P53 Phosphorylation Through MAP Kinases

Phosphorylation Of P53 Protein Triggered By Epstein-Barr Virus Latent Membrane Protein 1 In The Carcinogenesis Of Nasopharyngeal Carcinoma

The activation of p53 mediated by Epstein-Barr virus latent membrane protein 1 in SV40 large T-antigen transformed cells.

Role of Epstein-Barr Virus Encoded Latent Membrane Protein 1 in the Carcinogenesis of Nasopharyngeal Carcinoma.

Epstein-Barr Virus Oncoprotein LMP1 Mediates Survivin Upregulation by P53 Contributing to G1/S Cell Cycle Progression in Nasopharyngeal Carcinoma

Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53.

Phosphorylation And Nuclear Translocation Of Stat3 Regulated By The Epstein-Barr Virus Latent Membrane Protein 1 In Nasopharyngeal Carcinoma

Epstein–Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-κB p65 in human nasopharyngeal carcinoma cells

The Epstein-Barr Virus Encoded Latent Membrane Protein 1 Promotes Nuclear Factor-kappa B Activity in a Nasopharyngeal Carcinoma Cell Line

Cyclophilin A Binds to AKT1 and Facilitates the Tumorigenicity of Epstein-Barr Virus by Mediating the Activation of AKT/mTOR/NF-KB Positive Feedback Loop

Nuclear Accumulation of Epidermal Growth Factor Receptor and Acceleration of G1/S Stage by Epstein–Barr-encoded Oncoprotein Latent Membrane Protein 1

Epstein-Barr Virus Encoded Latent Membrane Protein 1 Regulates Mtor Signaling Pathway Genes Which Predict Poor Prognosis of Nasopharyngeal Carcinoma

Epstein-Barr Virus Latent Membrane Protein1(LMP1) Activated Ets-1 Expression Mediated by ERK in Nasopharyngeal Cell Line

Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.

Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.

Epstein-Barr Virus Encoded LMP1 Regulates Cyclin D1 Promoter Activity by Nuclear EGFR and STAT3 in CNE1 Cells

Cyclophilin A binds to AKT1 and facilitates the tumorigenicity of Epstein-Barr virus by mediating the activation of AKT/mTOR/NF-κB positive feedback loop.

Epstein-Barr Virus LMP1 Status in Relation to Apoptosis, P53 Expression and Leucocyte Infiltration in Nasopharyngeal Carcinoma.

Ubiquitination of MDM2 Modulated by Epstein-Barr Virus Encoded Latent Membrane Protein 1.

Nuclear Translocation of EGF Receptor Regulated by Epstein-Barr Virus Encoded Latent Membrane Protein 1

EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop